181
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Inhibition of endoplasmic reticulum stress through activation of MAPK/ERK signaling pathway attenuates hypoxia-mediated cardiomyocyte damage

&
Pages 532-537 | Received 18 Feb 2020, Accepted 28 Sep 2020, Published online: 06 Oct 2020
 

Abstract

The pathogenesis of post-infarction ischemia-induced myocardial damage is related to hypoxia-mediated cardiomyocyte damage. In the present study, we explored the roles of ERK signaling pathway and endoplasmic reticulum (ER) stress in hypoxia-related cardiomyocyte damage. H9c2 cells were cultured under hypoxia condition in the presence of the ERK activator. Our data demonstrated that ER stress was significantly activated by hypoxia in cardiomyocyte, as evidenced by increased expression of PERK and CHOP through immunofluorescence. Interestingly, application of ERK activator significantly reduced hypoxia-mediated ER stress. Besides, ERK activation also sustained cardiomyocyte viability in the presence of hypoxia, as evidenced by decreased activities of caspase-3 and caspase-9. Altogether, our results demonstrated that ERK activation significantly promoted cardiomyocyte survival through inhibition of ER stress. This finding provides a novel insight into the molecular mechanism underlying hypoxia-mediated cardiomyocyte damage. Besides, our results also offer a potential target for the treatment and prevention of post-infarction ischemia-related myocardial damage.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.